Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Johnson & Johnson Surgical Vision, Inc.

United States·US-MF-000038968

Last updated September 17, 2026

About

We want you to see better. Learn more about eye treatments and solutions for your eye health and vision needs at every stage of life.

Translated from the manufacturer's own website. Source

What Johnson & Johnson Surgical Vision, Inc. makes

The company manufactures posterior-chamber intraocular lenses (IOLs) for pseudophakic use, including single-piece and multifocal designs, as well as intraocular lens-insertion cartridges for surgical implantation. These devices are intended for cataract patients undergoing lens replacement procedures.

The portfolio includes Class IIb and Class III devices, with listings in the EU’s eudamed registry and the FDA’s Unique Device Identifier (UDI) database. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Johnson & Johnson Surgical Vision, Inc. manufacture?

Johnson & Johnson Surgical Vision, Inc. specializes in posterior-chamber intraocular lenses (IOLs) designed for pseudophakic use, which replace the natural lens during cataract surgery. Their portfolio also includes intraocular lens-insertion cartridges, which assist in the precise surgical implantation of these lenses. These devices are tailored for patients undergoing lens replacement procedures to restore vision clarity.

Where is Johnson & Johnson Surgical Vision, Inc. based, and what does that mean for its regulatory oversight?

Johnson & Johnson Surgical Vision, Inc. is based in the United States. This means its devices are subject to regulatory oversight by the FDA (Food and Drug Administration) in the U.S., while their European listings appear in the EU’s eudamed registry, reflecting compliance with EU medical device regulations. The company’s U.S. and EU operations ensure its products meet both regional standards for safety and performance.

Which regulatory registries list Johnson & Johnson Surgical Vision, Inc.’s devices, and why does this matter?

Johnson & Johnson Surgical Vision, Inc.’s devices are listed in the EU’s eudamed registry and the FDA’s Unique Device Identifier (UDI) database. These registries are critical because they provide transparent, searchable records of device details (e.g., model numbers, classifications) for healthcare professionals, regulators, and patients. Listing in these systems ensures traceability and compliance with global medical device reporting requirements.

How are Johnson & Johnson Surgical Vision, Inc.’s intraocular lenses classified under medical device regulations?

Johnson & Johnson Surgical Vision, Inc.’s intraocular lenses fall into Class IIb and Class III categories under medical device regulations. Class III designation applies to higher-risk devices (e.g., those supporting or sustaining life, or posing significant risks if they fail), while Class IIb covers devices with moderate risks, such as certain IOLs. This classification influences manufacturing controls, clinical evaluations, and post-market surveillance requirements to ensure safety and efficacy.

Why do some of Johnson & Johnson Surgical Vision, Inc.’s devices have different model numbers (e.g., ZCT4500140 vs. ZXT300I280), and what do these indicate?

The varied model numbers (e.g., ZCT4500140, ZXT300I280) reflect differences in design, functionality, or intended use within the company’s portfolio. For example, some may represent variations in lens optics (e.g., single-piece vs. multifocal), cartridge compatibility, or surgical application methods. These distinctions are critical for healthcare providers to select the appropriate device for a patient’s specific needs, as they influence outcomes like vision correction and surgical ease.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
Suite 200, 31 Technology Drive, Irvine, United States
LinkedIn
—
Phone
+1 714-227-8729
PRRC Contact
Gary Leaf
EUDAMED SRN
US-MF-000038968
FDA FEI Number
3012236936
DUNS Number
—

Catalogue (6112)

Page 5 of 123
DeviceModel / ReferenceRegistriesClassStatus
Zct4000055 ZCT4000055
EUDAMED
Class IIbActive
Zct4500275 ZCT4500275
EUDAMED
Class IIbActive
Zcu400i310 ZCU400I310
EUDAMED
Class IIbActive
Zct1000165 ZCT1000165
EUDAMED
Class IIbActive
Zct4500200 ZCT4500200
EUDAMED
Class IIbActive
Zct4500090 ZCT4500090
EUDAMED
Class IIbActive
Zct1000065 ZCT1000065
EUDAMED
Class IIbActive
Zxt300i095 ZXT300I095
EUDAMED
Class IIbActive
Zct7000330 ZCT7000330
EUDAMED
Class IIbActive
Zct8000120 ZCT8000120
EUDAMED
Class IIbActive
Zmt300i215 ZMT300I215
EUDAMED
Class IIbActive
Zxt300i170 ZXT300I170
EUDAMED
Class IIbActive
Zmt400i230 ZMT400I230
EUDAMED
Class IIbActive
Zct3000115 ZCT3000115
EUDAMED
Class IIbActive
Zct8000050 ZCT8000050
EUDAMED
Class IIbActive
Zct8000265 ZCT8000265
EUDAMED
Class IIbActive
Zct4000245 ZCT4000245
EUDAMED
Class IIbActive
Zct6000225 ZCT6000225
EUDAMED
Class IIbActive
Zct1000190 ZCT1000190
EUDAMED
Class IIbActive
Zcu400i240 ZCU400I240
EUDAMED
Class IIbActive
Zct1000090 ZCT1000090
EUDAMED
Class IIbActive
Zmt400i160 ZMT400I160
EUDAMED
Class IIbActive
Zct1000095 ZCT1000095
EUDAMED
Class IIbActive
Zct1000130 ZCT1000130
EUDAMED
Class IIbActive
Zmt300i075 ZMT300I075
EUDAMED
Class IIbActive
Zct3000155 ZCT3000155
EUDAMED
Class IIbActive
Zct3000250 ZCT3000250
EUDAMED
Class IIbActive
Zct8000280 ZCT8000280
EUDAMED
Class IIbActive
Zmt300i225 ZMT300I225
EUDAMED
Class IIbActive
Zxt300i245 ZXT300I245
EUDAMED
Class IIbActive
Zct4500220 ZCT4500220
EUDAMED
Class IIbActive
Zct6000130 ZCT6000130
EUDAMED
Class IIbActive
Zct3000145 ZCT3000145
EUDAMED
Class IIbActive
Zct7000325 ZCT7000325
EUDAMED
Class IIbActive
Zxt300i080 ZXT300I080
EUDAMED
Class IIbActive
Zmt300i240 ZMT300I240
EUDAMED
Class IIbActive
Zct4500255 ZCT4500255
EUDAMED
Class IIbActive
Zmt400i275 ZMT400I275
EUDAMED
Class IIbActive
Zct4000280 ZCT4000280
EUDAMED
Class IIbActive
Zct3000245 ZCT3000245
EUDAMED
Class IIbActive
Zct7000080 ZCT7000080
EUDAMED
Class IIbActive
Zct3000280 ZCT3000280
EUDAMED
Class IIbActive
Zct6000175 ZCT6000175
EUDAMED
Class IIbActive
Zmt300i055 ZMT300I055
EUDAMED
Class IIbActive
Zct4000205 ZCT4000205
EUDAMED
Class IIbActive
Zct6000150 ZCT6000150
EUDAMED
Class IIbActive
Zct6000075 ZCT6000075
EUDAMED
Class IIbActive
Zct1000195 ZCT1000195
EUDAMED
Class IIbActive
Zct6000100 ZCT6000100
EUDAMED
Class IIbActive
Zct4000210 ZCT4000210
EUDAMED
Class IIbActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (17)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Johnson & Johnson Surgical Vision, Inc. has 17 recall records initiated between May 9, 2018, and March 14, 2024, with statuses including open, classified, and terminated. The reasons cited involve intraocular lenses with specification deviations (e.g., cylinder axis misalignment, unintended toric marks, or expired distribution), software failures affecting alignment verification, packaging errors (e.g., incorrect cutter sizes or broken irrigation luer components), and manufacturing issues with devices like ophthalmic viscosurgical tools and phacoemulsification systems. Some records mention potential sterility breaches, endotoxin contamination, and nonconforming product releases.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 14, 2024Z-1755-2024—open, classified

Due to a manufacturing variation of the irrigation sleeves which could result in a missing port hole, this non-conformity could lead to insufficient flow to cool the ultrasonic phaco tip, potentially leading to an unstable anterior chamber which could cause possible harms.

Dec 12, 2023Z-0735-2024—open, classified

Due to intraocular lens containing an angle out of specification (OOS). The cylinder axis marks do not meet product specifications for the allowable angle between Low Power Meridian (LPM) and toric cylinder axis marks.

Jul 6, 2023Z-2289-2023—open, classified

Their is a potential that intraocular lenses (IOLs) were manufactured with unintended toric fiducial marks.

Jul 6, 2023Z-2288-2023—open, classified

Their is a potential that intraocular lenses (IOLs) were manufactured with unintended toric fiducial marks.

May 30, 2023Z-2247-2023—open, classified

Weld protrusion/physical gap between the housing and pack cover, may exceed design specification, due to a manufacturing issue, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1006-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1007-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1005-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Sep 7, 2022Z-0169-2023—open, classified

Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles flushed through the catheter irrigation may have thrombogenic/toxic effect.

Sep 1, 2022Z-0086-2023—open, classified

As a result of returned product complaints for Veritas Phaco packs related to broken or cracked irrigation luer due to a manufacturing issue.

Apr 6, 2022Z-1033-2022—open, classified

Potential breach in the sterility barrier for tray ring covers.

Aug 6, 2021Z-0028-2022—terminated

Nonconforming product was distributed in error. Product was nonconforming due endotoxin levels higher than both the Firm's internal endotoxin specification limit and the FDA recommended endotoxin specification limit. Product was released in error based on the results of additional testing performed during the investigation into release testing nonconformance.

Jan 27, 2021Z-1163-2021—terminated

Due to the release of nonconforming Intraocular Lenses (IOLs).

Dec 3, 2019Z-0867-2020—terminated

Ophthalmic viscosurgical device may be difficult to remove from the eye, leading to increased postoperative intraocular pressure requiring additional intervention. Also, reports of clogging of phacoemulsion equipment tubing, which may lead to delay in the procedure or ocular injury.

Sep 24, 2018Z-1893-2019—terminated

Packaging error, 20GA Vitrectomy Cutter may be found in a 25GA package. Use of a Vitrectomy cutter that is a different size than expected could lead to the need to alter the surgical technique, including corneal incision enlargement.

Jun 21, 2018Z-0464-2019—terminated

Expired intraocular lenses were distributed.

May 9, 2018Z-0066-2019—terminated

Software upgrade exhibits failures when executing Daily Alignment Verification (DAV), specifically, cuts on the plastic hemisphere during DAV do not match the intended cuts shown on the treatment overlay screen on the system GUI.